Farmmi is a Zhejiang-based processor of dried Shiitake and Mu Er mushrooms, with a small but growing cross-border logistics business in the United States, that now trades at roughly $0.10 against a Nasdaq minimum bid requirement of $1.00. The August 11, 2026 Nasdaq notification triggered a 180-day compliance period that runs through February 8, 2027, and management's only official cure is to push the closing bid above $1.00 for ten consecutive business days, implement a reverse stock split, or both. The capital structure has been compressed dramatically by three separate consolidations over the past four years, and the most recent June 2026 offering at $0.25 per share and a follow-on pre-funded warrant structure, with gross proceeds of approximately $3.0 million, show that the company can still access equity markets, but only at a fraction of the levels seen two years ago.
The operating story has been a steady contraction rather than a stable franchise. Total revenue fell to $28.0 million in fiscal 2025 from $64.1 million in fiscal 2024, which itself was down 41% from the $110.4 million posted in fiscal 2023, and the company reported a $53.4 million net loss for the most recent year against prior-year net income of roughly $2.2 million. The mushroom and Mu Er segments are still profitable on a gross basis, but scale has shrunk to the point where corporate overhead and asset write-downs dominate the income statement. A failed $99.1 million forestry asset acquisition that unwound in late September 2025 contributed materially to the loss, alongside a $42 million income tax expense that no prior year approached, and the result is a balance sheet whose $147.0 million of total assets now sits against $123.9 million of shareholders' equity.
The investment debate is therefore not about operations but about survival. With 13.8 million Class A shares outstanding at a market capitalization of about $3.8 million, the equity has the look of a stub trade whose value depends almost entirely on whether Nasdaq lets the company regain compliance, whether the next financing closes, and whether any of the company's product or logistics initiatives can produce the kind of growth that would justify a re-rating. The strongest counterargument is that the share class structure was just redesigned in December 2025 to create 50-to-1 supervoting Class B shares, an unusually defensive governance setup for a sub-$5 million market cap, which signals that management expects to remain in control of the franchise even as public float becomes increasingly small. Investors looking at FAMI should treat the position as a binary outcome tied to the compliance clock rather than a fundamentals-driven holding.